Interacting Drugs |
Carisoprodol and aspirin vs Nonsteroidal Anti-Inflammatory Agents |
Security Level |
|
Mechanism |
Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of Antiplatelet Agents. An increased risk of bleeding may occur. Nonsteroidal Anti-Inflammatory Agents may diminish the cardioprotective effect of Antiplatelet Agents. This interaction is likely specific to aspirin, and not to other antiplatelet agents. |
Management |
Monitor therapy |
Carisoprodol and aspirin vs Nonsteroidal Anti-Inflammatory Agents
Post Review about Carisoprodol and aspirin vs Nonsteroidal Anti-Inflammatory Agents Click here to cancel reply.
Other Interactions of Carisoprodol and aspirin
Other Interactions of Nonsteroidal Anti-Inflammatory Agents
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.